Avidity biosciences to participate in upcoming investor conference

San diego , nov. 21, 2023 /prnewswire/ -- avidity biosciences, inc. (nasdaq: rna), a biopharmaceutical company committed to delivering a new class of rna therapeutics called antibody oligonucleotide conjugates (aocs™), today announced that avidity management will be participating at the following upcoming conference: 6th annual evercore isi healthconx conference on november 28 at 9:30 a.m. pt/12:30 p.m.
RNA Ratings Summary
RNA Quant Ranking